Literature DB >> 19029213

Early phase clinical trials: communicating the uncertainties of 'magnitude of benefit' and 'likelihood of benefit'.

Nancy E Kass1.   

Abstract

Mesh：

Year:  2008        PMID： 19029213      PMCID： PMC3110657          DOI： 10.1177/1740774508098681

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  8 in total

Review 1.  Interventions to improve research participants' understanding in informed consent for research: a systematic review.

Authors:  James Flory; Ezekiel Emanuel
Journal:  JAMA       Date:  2004-10-06       Impact factor: 56.272

2.  Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions.

Authors:  L A Siminoff; J H Fetting
Journal:  Med Decis Making       Date:  1989 Oct-Dec       Impact factor: 2.583

3.  The effectiveness of patient verbalization on informed consent.

Authors:  V Wadey; C Frank
Journal:  Can J Surg       Date:  1997-04       Impact factor: 2.089

4.  Risks and benefits of phase 1 oncology trials, 1991 through 2002.

Authors:  Elizabeth Horstmann; Mary S McCabe; Louise Grochow; Seiichiro Yamamoto; Larry Rubinstein; Troy Budd; Dale Shoemaker; Ezekiel J Emanuel; Christine Grady
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

5.  Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?

Authors:  Nancy Kass; Holly Taylor; Linda Fogarty; Jeremy Sugarman; Steven N Goodman; Annallys Goodwin-Landher; Michael Carducci; Herbert Hurwitz
Journal:  J Empir Res Hum Res Ethics       Date:  2008-09       Impact factor: 1.742

6.  Response rates, duration of response, and dose response effects in phase I studies of antineoplastics.

Authors:  D D Von Hoff; J Turner
Journal:  Invest New Drugs       Date:  1991-02       Impact factor: 3.850

7.  "Why don't they just tell me straight, why allocate it?" The struggle to make sense of participating in a randomised controlled trial.

Authors:  Katie Featherstone; Jenny L Donovan
Journal:  Soc Sci Med       Date:  2002-09       Impact factor: 4.634

8.  Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience.

Authors:  H-T Arkenau; D Olmos; J E Ang; J de Bono; I Judson; S Kaye
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640
  8 in total
  4 in total

1.  The ethics of HIV "cure" research: what can we learn from consent forms?

Authors:  Gail E Henderson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

2.  Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Authors:  Rebecca D Pentz; Margaret White; R Donald Harvey; Zachary Luke Farmer; Yuan Liu; Colleen Lewis; Olga Dashevskaya; Taofeek Owonikoko; Fadlo R Khuri
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

Review 3.  Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009.

Authors:  Valerie A Jenkins; John L Anderson; Lesley J Fallowfield
Journal:  Support Care Cancer       Date:  2010-03-04       Impact factor: 3.603

4.  The clinical decision analysis using decision tree.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2014-10-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.